DEIRDRE EVANS-COSBY: Open Payments
NPI 1124029798 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$102 in 5 payments from 3 companies in 2025. Trend: 2023 $159 · 2024 $0 · 2025 $102
Food & beverage: $102
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
